Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone vs Levofloxacin on Cytokine Expression in Severe Pneumococcal Pneumonia
NCT00429975Phase 4Terminated
- Sponsor
- Hospital Universitari MútuaTerrassa
- Start
- Aug 2004
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin, ceftriaxone in Pneumococcal pneumonia (PP), sponsored by Hospital Universitari MútuaTerrassa. Started Aug 2004; status: terminated.
02
Drugs
levofloxacinceftriaxone
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT00429975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429975.